万维提示：
1、投稿方式：官网投稿。
2、期刊网址：
https://www.sciencedirect.com/journal/pulmonary-pharmacology-and-therapeutics
https://www.journals.elsevier.com/pulmonary-pharmacology-and-therapeutics#description
3、投稿网址：
https://www.editorialmanager.com/ypupt/default1.aspx
4、期刊刊期：双月刊，逢双月出版，一年出版6期。
2021年12月28日星期二
投稿须知【官网信息】
PULMONARY PHARMACOLOGY & THERAPEUTICS
Pulmonary Pharmacology & Therapeutics is concerned with lung pharmacology from molecular to clinical aspects. The subject matter encompasses the major diseases of the lung (including asthma, cystic fibrosis, pulmonary circulation, ARDS, carcinoma, bronchitis, emphysema) and drug delivery. Laboratory and clinical research on man and animals will be considered including studies related to chemotherapy of cancer, tuberculosis and infection. In addition to original research papers the journal will include review articles and book reviews.
For more details on how to write a world class paper, please visit our Pharmacology Author Resources page.
Authors are encouraged to submit video material or animation sequences to support and enhance your scientific research. For more information please see the paragraph on video data below.
Before submitting, please note the "Rules of 5" defining immediate rejection criteria of PPT:
1. Out of scope: The paper should report on the use of pharmacological or toxicological studies (positive or negative) that are directly related to Pulmonary Pharmacology & Therapeutics.
Immediate rejection criteria are:
a) Testing of extracts or plant parts that are not characterized
b) Case Reports or n=1 studies
2. Too preliminary: A paper must be based on a thorough and extensive study, using proper controls
Immediate rejection criteria are:
a) In vitro studies with a single dose, or very high concentration b) Single dose studies with very few animals, no dose-response studies c) No proper controls. d) Repetition or confirmation of an earlier work
3. Unethical: The study must have been carried under appropriate ethical approval for the study (either animal or human).
4. Inappropriate experiments or lacking essential detail
Immediate rejection criteria are: a) Wrong species or lacking details on the exact number of animals/subjects used
b) No details of structure if a new drug is used for the first time
5. Lack of novelty: The study must represent a novel approach to the field.
Immediate rejection criteria are:
a) Repetition of well known data
b) No advance of knowledge in the field
Types of paper
1. Regular papers. Original full-length research papers which have not been published previously, except in a preliminary form, may be submitted as regular papers.
2. Review articles. Review articles are welcome but should be topical and not just an overview of the literature. Before submission please contact one of the Chief Editors.
3. Letters to the Editor. Letters are published from time to time on matters of topical interest. These should be submitted via the online submission system by selecting the article type "Letter to the Editor".
4. Book reviews. Book reviews may be submitted to the Editor-in-Chief.
Submission checklist
You can use this list to carry out a final check of your submission before you send it to the journal for review. Please check the relevant section in this Guide for Authors for more details.
Ensure that the following items are present:
One author has been designated as the corresponding author with contact details:
• E-mail address (institutional e-mail address is required for the senior author and author submitting the manuscript.)
• Full postal address
All necessary files have been uploaded:
Manuscript:
• Include keywords
• All figures (include relevant captions)
• All tables (including titles, description, footnotes)
• Ensure all figure and table citations in the text match the files provided
• Indicate clearly if color should be used for any figures in print
Graphical Abstracts / Highlights files (where applicable)
Supplemental files (where applicable)
Further considerations
• Manuscript has been 'spell checked' and 'grammar checked'
• All references mentioned in the Reference List are cited in the text, and vice versa
• Permission has been obtained for use of copyrighted material from other sources (including the Internet)
• A competing interests statement is provided, even if the authors have no competing interests to declare
• Journal policies detailed in this guide have been reviewed
• Referee suggestions and contact details provided, based on journal requirements
……
更多详情：
https://www.elsevier.com/journals/pulmonary-pharmacology-and-therapeutics/1094-5539/guide-for-authors
